PIK3CB and B-cell non-Hodgkin lymphoma: In addition to variants that were common among non-neoplastic control samples, 25 potentially high-impact variants, predicted by the Ensembl Variant Effect Predictor, were found to affect PI3K and BTK only in lymphoid cell lines and primary B-cell lymphomas.